News

Medtronic, Inc. announced the first patients were enrolled in the Improve SCA Clinical Study, a first-of-its-kind study that will identify patients in developing countries at high risk for sudden cardiac arrest (SCA)–an abrupt loss of heart function that can lead to death in minutes–who have not previously experienced a life threatening arrhythmia (primary prevention patients). The first patients were enrolled at West China Hospital and Fuwai Hospital in China.

Home March 27, 2014
Home
News

Scientists at CBSET are reminding thought leaders in renal denervation that there is a seminal experimental and computational template for the more rational, comprehensive preclinical evaluation and optimization of renal denervation devices that can be utilized during preclinical and clinical development.

Home March 27, 2014
Home
News

Atherotech Diagnostics Lab opened its patient service center in Sarasota, Fla.

Home March 27, 2014
Home
Technology

The U.S. Food and Drug Administration (FDA) granted 510(k) clearance for three new digital angiography systems from Shimadzu Medical Systems. These are the ceiling-mounted Trinias, the floor-mounted Trinias, and the Biplane models.

Home March 27, 2014
Home
News

Manhattan Scientifics announced a collaboration with Azano Biotech that will make NanoMRX Precision Nanoparticles available for purchase.

Home March 26, 2014
Home
Feature

InspireMD Inc. has enrolled the first patient into the CARENET (CARotid Embolic protection study using microNET) multi-center European clinical trial for the new CGuard carotid embolic protection system.

Home March 26, 2014
Home
News

Based on its recent analysis of the superconductor technology for MRI market, Frost & Sullivan recognizes Cutting Edge Superconductors, Inc. with the 2013 North American Frost & Sullivan Award for Technology Innovation Leadership.

Home March 26, 2014
Home
Technology

St. Jude Medical Inc. has received approval from the U.S. Food and Drug Administration (FDA) for the Allure Quadra Cardiac Resynchronization Therapy Pacemaker (CRT-P), which provides additional pacing innovations for physicians to treat patients with heart failure (HF). The company also announced FDA approvals for the Assurity pacemaker and Endurity pacemaker families of devices.

Home March 26, 2014
Home
News

Aerotel Medical Systems has received the CE Mark approval for its new electrocardiogram (ECG) devices, HeartView P12/8i and HeartView 12L.

Home March 25, 2014
Home
biotronik, MRI safe ICD
Feature

Biotronik has announced the Food and Drug Administration (FDA) has approved the expansion of Biotronik’s ongoing ProMRI clinical trial. The new phase of the trial (Phase C) will study the company’s ProMRI technology in implantable cardioverter-defibrillator (ICD) devices. Biotronik is the only company in the world with an ICD that is approved for investigational use in a magnetic resonance imaging (MRI) scanner. The ongoing ProMRI study is the first step in making this standalone technology available in the United States.

Home March 25, 2014
Home
Technology

The NDS Surgical Imaging (NDSsi) Dome S6c diagnostic display is a 6-megapixel (MP) LED widescreen model, and the latest addition to the S-series product family. It features 30-inch widescreen viewing, can be utilized as a single 6 MP or in dual 3 MP bezel-free format and provides both grayscale and color images. A native resolution of 3,280 by 2,048 makes it ideal for viewing a wide range of medical imaging modalities including computed radiography (CR), digital radiography (DR), magnetic resonance (MR), computed tomography (CT), positron emission tomography/computed tomography (PET/CT), ultrasound and 3-D volume rendering. Offering 800cd/m² high-bright LED-backlight technology and 1,000:1 contrast ratio, the Dome S6c delivers a new benchmark in optical clarity and image brilliance in varying ambient light environments.

Home March 25, 2014
Home
News

As long as inexpensive statins, which lower cholesterol, are readily available and patients do not mind taking them, it does not make sense to do a heart comuted tomography (CT) scan to measure how much plaque has built up in a patient’s coronary arteries before prescribing the pills, according to a new study by researchers at UC San Francisco.

Home March 25, 2014
Home
News

Patient enrollment has been completed four months ahead of plan in the Phase III clinical trial EUCLID study for AstraZeneca's ticagrelor (Brilinta) tablets. Part of PARTHENON, AstraZeneca’s largest clinical trial program, EUCLID has randomized more than 13,500 patients globally with peripheral artery disease (PAD); approximately 20 percent are patients in the United States from more than 300 active clinical trial sites across the country. EUCLID is designed to evaluate the effects of ticagrelor (monotherapy) compared to clopidogrel (monotherapy) on cardiovascular (CV) events and safety in PAD patients. Ticagrelor is currently not approved for the treatment of patients with PAD.

Home March 25, 2014
Home
CT scan, radiation dose management, UC Davis
Feature

UC Davis clinicians and physicists have recommended new strategies to make computed tomography (CT) safer, including adoption of a new metric for dose measurement, ways to manage exposure protocols that differ by CT brand and specific approaches to reduce exposure during needle biopsies.

Home March 25, 2014
Home
Technology

Digisonics will showcase its upcoming DigiView Release 3.8.4. for its Cardiovascular Information System (CVIS) at this year’s American College of Cardiology (ACC) annual scientific session in Washington, D.C., March 28-31.

Home March 25, 2014
Home
Subscribe Now